Barclays
DBD icon

Barclays’s Diebold Nixdorf DBD Stock Holding History

Barclays’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Buy
7,350
+56
+0.8% +$4.5K ﹤0.01% 3092
2026
Q1 		$550K Sell
7,294
-31,278
-81% -$2.3M ﹤0.01% 3141
2025
Q4 		$2.62M Buy
38,572
+2,307
+6% +$144K ﹤0.01% 2732
2025
Q3 		$2.07M Sell
36,265
-11,369
-24% -$674K ﹤0.01% 2866
2025
Q2 		$2.64M Buy
47,634
+19,013
+66% +$892K ﹤0.01% 2632
2025
Q1 		$1.25M Sell
28,621
-12,175
-30% -$531K ﹤0.01% 2968
2024
Q4 		$1.76M Sell
40,796
-93,787
-70% -$4.22M ﹤0.01% 2982
2024
Q3 		$6.01M Sell
134,583
-82,101
-38% -$3.4M ﹤0.01% 1931
2024
Q2 		$8.34M Buy
216,684
+136,437
+170% +$5.2M ﹤0.01% 1269
2024
Q1 		$2.76M Buy
80,247
+28,736
+56% +$923K ﹤0.01% 2301
2023
Q4 		$1.49M Buy
+51,511
New +$1.17M ﹤0.01% 3149

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $368M AUM 57.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's DBD Position: Q2 2026 in Review

Barclays increased its Diebold Nixdorf (DBD) stake by 0.77% in Q2 2026, buying an estimated $4.5K and bringing the position to 7,350 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #3092.

Barclays first reported a position in DBD in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.34M in Q2 2024. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Barclays held 7,350 shares of Diebold Nixdorf worth $625K as of Q2 2026.
  • Barclays bought 56 Diebold Nixdorf shares in Q2 2026, an estimated $4.5K.
  • Diebold Nixdorf made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3092 holding.
  • Barclays first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 11 quarters since.
  • Barclays's Diebold Nixdorf position peaked at $8.34M in Q2 2024.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.